Seeking Alpha

medley

medley
Send Message
View as an RSS Feed
Latest  |  Highest rated
  • Hyperion Therapeutics (HPTX -1.2%) names Daniel G. Welch to its Board of Directors. Mr. Welch currently serves as Chairman, CEO and President of InterMune (ITMN +1%). Mr. Welch brings more than 30 years of experience in the biotechnology and pharmaceutical industries. [View news story]
    so what?
    what does this do for ITMN?
    Aug 28 04:29 PM | Likes Like |Link to Comment
COMMENTS STATS
1 Comment
0 Likes